As recent studies have shown that ATF1 is OE in several cancers, including hepatocellular carcinoma, non-small cell lung cancer, esophageal squamous cell carcinoma, and cervical cancer, specific inhibitors for ATF1 are being developed. The gene discussed is ATF1; the disease is cancer.